{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:25:19Z","timestamp":1788535519454,"version":"build-2803163510"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI185559"],"award-info":[{"award-number":["R01 AI185559"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R37 AI050234"],"award-info":[{"award-number":["R37 AI050234"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21 AI159558"],"award-info":[{"award-number":["R21 AI159558"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI1147628"],"award-info":[{"award-number":["R01 AI1147628"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI182318"],"award-info":[{"award-number":["R01 AI182318"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI169892"],"award-info":[{"award-number":["R01 AI169892"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI1147628"],"award-info":[{"award-number":["R01 AI1147628"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI182318"],"award-info":[{"award-number":["R01 AI182318"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI1147628"],"award-info":[{"award-number":["R01 AI1147628"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI169892"],"award-info":[{"award-number":["R01 AI169892"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-094768"],"award-info":[{"award-number":["INV-094768"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-039628"],"award-info":[{"award-number":["INV-039628"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004167","name":"Medicines for Malaria Venture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004167","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    New antimalarial drugs are needed to combat the current emergence and spread of\n                    <jats:italic>Plasmodium falciparum<\/jats:italic>\n                    parasite resistance to artemisinin-based combination therapies. Here, we characterize ZY19489, a triaminopyrimidine presently in a Phase Ib clinical trial. Asexual blood-stage parasites pressured with ZY19489 acquire low-grade resistance, mediated by a novel mutation in the\n                    <jats:italic>P. falciparum<\/jats:italic>\n                    chloroquine resistance transporter (PfCRT) that causes slow growth rates and a substantial fitness cost. ZY19489-resistant parasites lose their chloroquine resistance status and become hypersusceptible to piperaquine\u00a0(PPQ), an artemisinin-based combination partner drug. Uptake studies in proteoliposomes loaded with drug-resistant PfCRT isoforms demonstrate that ZY19489 can block mutant PfCRT-mediated PPQ and chloroquine transport. In parasites, PfCRT mutant variants can mediate PPQ and chloroquine resistance via their efflux out of the digestive vacuole. Our findings evoke a scenario of an evolutionary trap whereby resistance to ZY19489 can block PPQ and chloroquine efflux and thereby restore their activity. Metabolomic studies show that ZY19489 leads to significantly reduced intracellular levels of short hemoglobin-derived peptides (a natural substrate of PfCRT) and accumulation of pyrimidine deoxynucleotides. Our results present a possible marker for tracking the evolution of clinical resistance to ZY19489 and a rationale for pairing this molecule with PPQ to generate a resistance-refractory combination.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-70914-1","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T12:38:19Z","timestamp":1775047099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Collateral hypersensitivity between ZY19489 and piperaquine neutralizes PfCRT-mediated drug efflux and Plasmodium falciparum resistance"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8680-2351","authenticated-orcid":false,"given":"John","family":"Okombo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tolla","family":"Ndiaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarrick","family":"Qahash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3279-6894","authenticated-orcid":false,"given":"Igor M. R.","family":"Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4046-5756","authenticated-orcid":false,"given":"Eva","family":"Gil-Iturbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Hagenah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Bridgford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius","family":"Bonatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt E.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2923-6060","authenticated-orcid":false,"given":"Tomas","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5476-9753","authenticated-orcid":false,"given":"Sunil K.","family":"Narwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0432-8955","authenticated-orcid":false,"given":"Lily V.","family":"Orta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isla","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish K.","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charisse Flerida A.","family":"Pasaje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5815-9717","authenticated-orcid":false,"given":"Heekuk","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7187-0818","authenticated-orcid":false,"given":"Rafael V. C.","family":"Guido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Bel\u00e9n","family":"Jim\u00e9nez-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8800-8132","authenticated-orcid":false,"given":"I\u00f1igo","family":"Angulo-Barturen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6250-8796","authenticated-orcid":false,"given":"Jacquin C.","family":"Niles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Mancia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9798-4768","authenticated-orcid":false,"given":"Anne-Catrin","family":"Uhlemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9605-0154","authenticated-orcid":false,"given":"Sachel","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8620-827X","authenticated-orcid":false,"given":"Matthias","family":"Quick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4049-2113","authenticated-orcid":false,"given":"Elizabeth A.","family":"Winzeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5594-3204","authenticated-orcid":false,"given":"Didier","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6173-5882","authenticated-orcid":false,"given":"Manuel","family":"Llin\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7797-8638","authenticated-orcid":false,"given":"Vandana","family":"Thathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6753-8938","authenticated-orcid":false,"given":"David A.","family":"Fidock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"70914_CR1","unstructured":"WHO. World Health Organization. World Malaria Report 2025. https:\/\/www.who.int\/teams\/global\u2013malaria\u2013programme\/reports\/world\u2013malaria\u2013report\u20132025."},{"key":"70914_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(24)00172-1","volume":"6","author":"S Mihreteab","year":"2025","unstructured":"Mihreteab, S. et al. The spread of molecular markers of artemisinin partial resistance and diagnostic evasion in Eritrea: a retrospective molecular epidemiology study. Lancet Microbe 6, 100930 (2025).","journal-title":"Lancet Microbe"},{"key":"70914_CR3","doi-asserted-by":"publisher","first-page":"e591","DOI":"10.1016\/S1473-3099(24)00141-5","volume":"24","author":"PJ Rosenthal","year":"2024","unstructured":"Rosenthal, P. J. et al. The emergence of artemisinin partial resistance in Africa: how do we respond? Lancet Infect. Dis. 24, e591\u2013e600 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"70914_CR4","doi-asserted-by":"publisher","first-page":"e0010924","DOI":"10.1128\/cmr.00109-24","volume":"37","author":"NJ White","year":"2024","unstructured":"White, N. J. & Chotivanich, K. Artemisinin-resistant malaria. Clin. Microbiol Rev. 37, e0010924 (2024).","journal-title":"Clin. Microbiol Rev."},{"key":"70914_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0140-6736(23)02511-4","volume":"403","author":"MS Datoo","year":"2024","unstructured":"Datoo, M. S. et al. Safety and efficacy of malaria vaccine candidate R21\/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial. Lancet 403, 533\u2013544 (2024).","journal-title":"Lancet"},{"key":"70914_CR6","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.cell.2022.01.028","volume":"185","author":"P Sinnis","year":"2022","unstructured":"Sinnis, P. & Fidock, D. A. The RTS,S vaccine-a chance to regain the upper hand against malaria? Cell 185, 750\u2013754 (2022).","journal-title":"Cell"},{"key":"70914_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7715","volume":"6","author":"PS Hameed","year":"2015","unstructured":"Hameed, P. S. et al. Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate. Nat. Commun. 6, 6715 (2015).","journal-title":"Nat. Commun."},{"key":"70914_CR8","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S1473-3099(21)00679-4","volume":"22","author":"BE Barber","year":"2022","unstructured":"Barber, B. E. et al. Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study. Lancet Infect. Dis. 22, 879\u2013890 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"70914_CR9","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.05236-22","volume":"11","author":"O Kreutzfeld","year":"2023","unstructured":"Kreutzfeld, O. et al. Susceptibility of Ugandan Plasmodium falciparum isolates to the antimalarial drug pipeline. Microbiol Spectr. 11, e0523622 (2023).","journal-title":"Microbiol Spectr."},{"key":"70914_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41579-024-01099-x","volume":"23","author":"J Okombo","year":"2025","unstructured":"Okombo, J. & Fidock, D. A. Towards next-generation treatment options to combat Plasmodium falciparum malaria. Nat. Rev. Microbiol 23, 178\u2013191 (2025).","journal-title":"Nat. Rev. Microbiol"},{"key":"70914_CR11","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1021\/acsinfecdis.3c00588","volume":"10","author":"JCR Lindblom","year":"2024","unstructured":"Lindblom, J. C. R., Zhang, X. & Lehane, A. M. A pH fingerprint assay to identify inhibitors of multiple validated and potential antimalarial drug targets. ACS Infect. Dis. 10, 1185\u20131200 (2024).","journal-title":"ACS Infect. Dis."},{"key":"70914_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38774-1","volume":"14","author":"K Kumpornsin","year":"2023","unstructured":"Kumpornsin, K. et al. Generation of a mutator parasite to drive resistome discovery in Plasmodium falciparum. Nat. Commun. 14, 3059 (2023).","journal-title":"Nat. Commun."},{"key":"70914_CR13","doi-asserted-by":"publisher","first-page":"e02731","DOI":"10.1128\/mBio.02731-18","volume":"10","author":"SK Dhingra","year":"2019","unstructured":"Dhingra, S. K. et al. Global spread of mutant PfCRT and its pleiotropic impact on Plasmodium falciparum multidrug resistance and fitness. mBio 10, e02731\u201302718 (2019).","journal-title":"mBio"},{"key":"70914_CR14","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/nmeth.2143","volume":"9","author":"J Straimer","year":"2012","unstructured":"Straimer, J. et al. Site-specific genome editing in Plasmodium falciparum using engineered zinc-finger nucleases. Nat. Methods 9, 993\u2013998 (2012).","journal-title":"Nat. Methods"},{"key":"70914_CR15","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1086\/507115","volume":"194","author":"AB Sidhu","year":"2006","unstructured":"Sidhu, A. B. et al. Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J. Infect. Dis. 194, 528\u2013535 (2006).","journal-title":"J. Infect. Dis."},{"key":"70914_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi2364","volume":"9","author":"S Mok","year":"2023","unstructured":"Mok, S. et al. Mapping the genomic landscape of multidrug resistance in Plasmodium falciparum and its impact on parasite fitness. Sci. Adv. 9, eadi2364 (2023).","journal-title":"Sci. Adv."},{"key":"70914_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41586-019-1795-x","volume":"576","author":"J Kim","year":"2019","unstructured":"Kim, J. et al. Structure and drug resistance of the Plasmodium falciparum transporter PfCRT. Nature 576, 315\u2013320 (2019).","journal-title":"Nature"},{"key":"70914_CR18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1146\/annurev-micro-020518-115546","volume":"74","author":"KJ Wicht","year":"2020","unstructured":"Wicht, K. J., Mok, S. & Fidock, D. A. Molecular mechanisms of drug resistance in Plasmodium falciparum malaria. Annu Rev. Microbiol 74, 431\u2013454 (2020).","journal-title":"Annu Rev. Microbiol"},{"key":"70914_CR19","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1128\/AAC.00032-10","volume":"54","author":"M Imwong","year":"2010","unstructured":"Imwong, M. et al. Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum. Antimicrob. Agents Chemother. 54, 2886\u20132892 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"70914_CR20","doi-asserted-by":"publisher","first-page":"e20212","DOI":"10.1371\/journal.pone.0020212","volume":"6","author":"MI Veiga","year":"2011","unstructured":"Veiga, M. I. et al. Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance. PLoS One 6, e20212 (2011).","journal-title":"PLoS One"},{"key":"70914_CR21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/mmi.13397","volume":"101","author":"CL Ng","year":"2016","unstructured":"Ng, C. L. et al. CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugs. Mol. Microbiol 101, 381\u2013393 (2016).","journal-title":"Mol. Microbiol"},{"key":"70914_CR22","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41564-017-0007-4","volume":"2","author":"M Vanaerschot","year":"2017","unstructured":"Vanaerschot, M. et al. Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity. Nat. Microbiol 2, 1403\u20131414 (2017).","journal-title":"Nat. Microbiol"},{"key":"70914_CR23","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.1128\/AAC.00519-09","volume":"53","author":"MB Jimenez-Diaz","year":"2009","unstructured":"Jimenez-Diaz, M. B. et al. Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rgammanull mice engrafted with human erythrocytes. Antimicrob. Agents Chemother. 53, 4533\u20134536 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"70914_CR24","doi-asserted-by":"publisher","first-page":"e2252","DOI":"10.1371\/journal.pone.0002252","volume":"3","author":"I Angulo-Barturen","year":"2008","unstructured":"Angulo-Barturen, I. et al. A murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes. PLoS One 3, e2252 (2008).","journal-title":"PLoS One"},{"key":"70914_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature14451","volume":"522","author":"B Baragana","year":"2015","unstructured":"Baragana, B. et al. A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature 522, 315\u2013320 (2015).","journal-title":"Nature"},{"key":"70914_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29688-5","volume":"13","author":"LE de Vries","year":"2022","unstructured":"de Vries, L. E. et al. Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183. Nat. Commun. 13, 2158 (2022).","journal-title":"Nat. Commun."},{"key":"70914_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.chembiol.2021.07.010","volume":"29","author":"RL Summers","year":"2022","unstructured":"Summers, R. L. et al. Chemogenomics identifies acetyl-coenzyme A synthetase as a target for malaria treatment and prevention. Cell Chem. Biol. 29, 191\u2013201 e198 (2022).","journal-title":"Cell Chem. Biol."},{"key":"70914_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40974-8","volume":"14","author":"E Stadler","year":"2023","unstructured":"Stadler, E. et al. Propensity of selecting mutant parasites for the antimalarial drug cabamiquine. Nat. Commun. 14, 5205 (2023).","journal-title":"Nat. Commun."},{"key":"70914_CR29","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.chembiol.2019.11.009","volume":"27","author":"JM Murithi","year":"2020","unstructured":"Murithi, J. M. et al. Combining stage specificity and metabolomic profiling to advance antimalarial drug discovery. Cell Chem. Biol. 27, 158\u2013171 (2020).","journal-title":"Cell Chem. Biol."},{"key":"70914_CR30","doi-asserted-by":"publisher","first-page":"e1010926","DOI":"10.1371\/journal.ppat.1010926","volume":"18","author":"J Okombo","year":"2022","unstructured":"Okombo, J. et al. Piperaquine-resistant PfCRT mutations differentially impact drug transport, hemoglobin catabolism and parasite physiology in Plasmodium falciparum asexual blood stages. PLoS Pathog. 18, e1010926 (2022).","journal-title":"PLoS Pathog."},{"key":"70914_CR31","doi-asserted-by":"publisher","first-page":"6635","DOI":"10.1128\/AAC.01224-16","volume":"60","author":"EL Allman","year":"2016","unstructured":"Allman, E. L., Painter, H. J., Samra, J., Carrasquilla, M. & Llinas, M. Metabolomic profiling of the Malaria Box reveals antimalarial target pathways. Antimicrob. Agents Chemother. 60, 6635\u20136649 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"70914_CR32","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/infdis\/jiv372","volume":"213","author":"SA Cobbold","year":"2016","unstructured":"Cobbold, S. A. et al. Metabolic dysregulation induced in Plasmodium falciparum by dihydroartemisinin and other front-line antimalarial drugs. J. Infect. Dis. 213, 276\u2013286 (2016).","journal-title":"J. Infect. Dis."},{"key":"70914_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00572-x","volume":"8","author":"DA Baker","year":"2017","unstructured":"Baker, D. A. et al. A potent series targeting the malarial cGMP-dependent protein kinase clears infection and blocks transmission. Nat. Commun. 8, 430 (2017).","journal-title":"Nat. Commun."},{"key":"70914_CR34","doi-asserted-by":"publisher","first-page":"5392","DOI":"10.1073\/pnas.1218412110","volume":"110","author":"M Chugh","year":"2013","unstructured":"Chugh, M. et al. Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA. 110, 5392\u20135397 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70914_CR35","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.1073\/pnas.0307720101","volume":"101","author":"PS Sijwali","year":"2004","unstructured":"Sijwali, P. S. & Rosenthal, P. J. Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum. Proc. Natl. Acad. Sci. USA. 101, 4384\u20134389 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70914_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2174\/138620710790980496","volume":"13","author":"MD Carter","year":"2010","unstructured":"Carter, M. D., Phelan, V. V., Sandlin, R. D., Bachmann, B. O. & Wright, D. W. Lipophilic mediated assays for beta-hematin inhibitors. Comb. Chem. High. Throughput Screen 13, 285\u2013292 (2010).","journal-title":"Comb. Chem. High. Throughput Screen"},{"key":"70914_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-015-0729-9","volume":"14","author":"JM Combrinck","year":"2015","unstructured":"Combrinck, J. M. et al. Optimization of a multi-well colorimetric assay to determine haem species in Plasmodium falciparum in the presence of anti-malarials. Malar. J. 14, 253 (2015).","journal-title":"Malar. J."},{"key":"70914_CR38","doi-asserted-by":"publisher","first-page":"e976","DOI":"10.1093\/infdis\/jiae617","volume":"231","author":"LM Hagenah","year":"2025","unstructured":"Hagenah, L. M. et al. Plasmodium falciparum African PfCRT mutant isoforms conducive to piperaquine resistance are infrequent and impart a major fitness cost. J. Infect. Dis. 231, e976\u2013e985 (2025).","journal-title":"J. Infect. Dis."},{"key":"70914_CR39","doi-asserted-by":"publisher","first-page":"e1004382","DOI":"10.1371\/journal.pgen.1004382","volume":"10","author":"CP Sanchez","year":"2014","unstructured":"Sanchez, C. P. et al. A HECT ubiquitin-protein ligase as a novel candidate gene for altered quinine and quinidine responses in Plasmodium falciparum. PLoS Genet 10, e1004382 (2014).","journal-title":"PLoS Genet"},{"key":"70914_CR40","doi-asserted-by":"publisher","first-page":"e1011436","DOI":"10.1371\/journal.ppat.1011436","volume":"19","author":"GM Gomez","year":"2023","unstructured":"Gomez, G. M. et al. PfCRT mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport. PLoS Pathog. 19, e1011436 (2023).","journal-title":"PLoS Pathog."},{"key":"70914_CR41","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1021\/acs.biochem.2c00669","volume":"62","author":"A Willems","year":"2023","unstructured":"Willems, A. et al. Structures of Plasmodium falciparum chloroquine resistance transporter (PfCRT) isoforms and their interactions with chloroquine. Biochemistry 62, 1093\u20131110 (2023).","journal-title":"Biochemistry"},{"key":"70914_CR42","doi-asserted-by":"publisher","first-page":"36336","DOI":"10.1074\/jbc.M114.614206","volume":"289","author":"S Bellanca","year":"2014","unstructured":"Bellanca, S. et al. Multiple drugs compete for transport via the Plasmodium falciparum chloroquine resistance transporter at distinct but interdependent sites. J. Biol. Chem. 289, 36336\u201336351 (2014).","journal-title":"J. Biol. Chem."},{"key":"70914_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58244-0","volume":"16","author":"JD Tanner","year":"2025","unstructured":"Tanner, J. D., Richards, S. N. & Corry, B. Molecular basis of the functional conflict between chloroquine and peptide transport in the malaria parasite chloroquine resistance transporter PfCRT. Nat. Commun. 16, 2987 (2025).","journal-title":"Nat. Commun."},{"key":"70914_CR44","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1021\/acs.biochem.0c00247","volume":"59","author":"B Riegel","year":"2020","unstructured":"Riegel, B. & Roepe, P. D. Altered drug transport by Plasmodium falciparum chloroquine resistance transporter isoforms harboring mutations associated with piperaquine resistance. Biochemistry 59, 2484\u20132493 (2020).","journal-title":"Biochemistry"},{"key":"70914_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw229","volume":"4","author":"AR Taylor","year":"2017","unstructured":"Taylor, A. R. et al. Artemether-lumefantrine and dihydroartemisinin-piperaquine exert inverse selective pressure on Plasmodium falciparum drug sensitivity-associated haplotypes in Uganda. Open Forum Infect. Dis. 4, ofw229 (2017).","journal-title":"Open Forum Infect. Dis."},{"key":"70914_CR46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pt.2020.09.011","volume":"37","author":"RW van der Pluijm","year":"2021","unstructured":"van der Pluijm, R. W., Amaratunga, C., Dhorda, M. & Dondorp, A. M. Triple artemisinin-based combination therapies for malaria - a new paradigm? Trends Parasitol. 37, 15\u201324 (2021).","journal-title":"Trends Parasitol."},{"key":"70914_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11553","volume":"7","author":"MI Veiga","year":"2016","unstructured":"Veiga, M. I. et al. Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies. Nat. Commun. 7, 11553 (2016).","journal-title":"Nat. Commun."},{"key":"70914_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1239274","volume":"11","author":"W Xu","year":"2023","unstructured":"Xu, W. et al. Molecular markers associated with drug resistance in Plasmodium falciparum parasites in central Africa between 2016 and 2021. Front Public Health 11, 1239274 (2023).","journal-title":"Front Public Health"},{"key":"70914_CR49","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.85023","volume":"12","author":"REK Mandt","year":"2023","unstructured":"Mandt, R. E. K. et al. Diverse evolutionary pathways challenge the use of collateral sensitivity as a strategy to suppress resistance. Elife 12, e85023 (2023).","journal-title":"Elife"},{"key":"70914_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08098-6","volume":"10","author":"D Nichol","year":"2019","unstructured":"Nichol, D. et al. Antibiotic collateral sensitivity is contingent on the repeatability of evolution. Nat. Commun. 10, 334 (2019).","journal-title":"Nat. Commun."},{"key":"70914_CR51","doi-asserted-by":"publisher","first-page":"e1005976","DOI":"10.1371\/journal.ppat.1005976","volume":"12","author":"SJ Gabryszewski","year":"2016","unstructured":"Gabryszewski, S. J. et al. Evolution of fitness cost-neutral mutant PfCRT conferring P. falciparum 4-aminoquinoline drug resistance is accompanied by altered parasite metabolism and digestive vacuole physiology. PLoS Pathog. 12, e1005976 (2016).","journal-title":"PLoS Pathog."},{"key":"70914_CR52","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01832-23","volume":"15","author":"LM Hagenah","year":"2024","unstructured":"Hagenah, L. M. et al. Additional PfCRT mutations driven by selective pressure for improved fitness can result in the loss of piperaquine resistance and altered Plasmodium falciparum physiology. mBio 15, e0183223 (2024).","journal-title":"mBio"},{"key":"70914_CR53","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/S1473-3099(19)30543-2","volume":"19","author":"SK Dhingra","year":"2019","unstructured":"Dhingra, S. K., Small-Saunders, J. L., Menard, D. & Fidock, D. A. Plasmodium falciparum resistance to piperaquine driven by PfCRT. Lancet Infect. Dis. 19, 1168\u20131169 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"70914_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05652-0","volume":"9","author":"LS Ross","year":"2018","unstructured":"Ross, L. S. et al. Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine. Nat. Commun. 9, 3314 (2018).","journal-title":"Nat. Commun."},{"key":"70914_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17781-6","volume":"11","author":"SH Shafik","year":"2020","unstructured":"Shafik, S. H. et al. The natural function of the malaria parasite\u2019s chloroquine resistance transporter. Nat. Commun. 11, 3922 (2020).","journal-title":"Nat. Commun."},{"key":"70914_CR56","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1242\/jcs.061499","volume":"123","author":"N Abu Bakar","year":"2010","unstructured":"Abu Bakar, N., Klonis, N., Hanssen, E., Chan, C. & Tilley, L. Digestive-vacuole genesis and endocytic processes in the early intraerythrocytic stages of Plasmodium falciparum. J. Cell Sci. 123, 441\u2013450 (2010).","journal-title":"J. Cell Sci."},{"key":"70914_CR57","first-page":"406","volume":"129","author":"SC Xie","year":"2016","unstructured":"Xie, S. C. et al. Haemoglobin degradation underpins the sensitivity of early ring stage Plasmodium falciparum to artemisinins. J. Cell Sci. 129, 406\u2013416 (2016).","journal-title":"J. Cell Sci."},{"key":"70914_CR58","doi-asserted-by":"publisher","first-page":"5268","DOI":"10.1021\/bi00183a033","volume":"33","author":"KK Seymour","year":"1994","unstructured":"Seymour, K. K., Lyons, S. D., Phillips, L., Rieckmann, K. H. & Christopherson, R. I. Cytotoxic effects of inhibitors of de novo pyrimidine biosynthesis upon Plasmodium falciparum. Biochemistry 33, 5268\u20135274 (1994).","journal-title":"Biochemistry"},{"key":"70914_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10727","volume":"7","author":"SM Ganesan","year":"2016","unstructured":"Ganesan, S. M., Falla, A., Goldfless, S. J., Nasamu, A. S. & Niles, J. C. Synthetic RNA-protein modules integrated with native translation mechanisms to control gene expression in malaria parasites. Nat. Commun. 7, 10727 (2016).","journal-title":"Nat. Commun."},{"key":"70914_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77644-4","volume":"11","author":"AS Nasamu","year":"2021","unstructured":"Nasamu, A. S. et al. An integrated platform for genome engineering and gene expression perturbation in Plasmodium falciparum. Sci. Rep. 11, 342 (2021).","journal-title":"Sci. Rep."},{"key":"70914_CR61","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1093\/nar\/29.3.850","volume":"29","author":"K Deitsch","year":"2001","unstructured":"Deitsch, K., Driskill, C. & Wellems, T. Transformation of malaria parasites by the spontaneous uptake and expression of DNA from human erythrocytes. Nucleic Acids Res. 29, 850\u2013853 (2001).","journal-title":"Nucleic Acids Res"},{"key":"70914_CR62","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-1-4939-9550-9_9","volume":"2013","author":"CL Ng","year":"2019","unstructured":"Ng, C. L. & Fidock, D. A. Plasmodium falciparum in vitro drug resistance selections and gene editing. Methods Mol. Biol. 2013, 123\u2013140 (2019).","journal-title":"Methods Mol. Biol."},{"key":"70914_CR63","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296\u2013W303 (2018).","journal-title":"Nucleic Acids Res"},{"key":"70914_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39969-2","volume":"14","author":"F Berger","year":"2023","unstructured":"Berger, F. et al. pH-dependence of the Plasmodium falciparum chloroquine resistance transporter is linked to the transport cycle. Nat. Commun. 14, 4234 (2023).","journal-title":"Nat. Commun."},{"key":"70914_CR65","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/pro.3280","volume":"27","author":"E Jurrus","year":"2018","unstructured":"Jurrus, E. et al. Improvements to the APBS biomolecular solvation software suite. Protein Sci. 27, 112\u2013128 (2018).","journal-title":"Protein Sci."},{"key":"70914_CR66","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1021\/acs.jcim.1c00075","volume":"61","author":"X Pan","year":"2021","unstructured":"Pan, X., Wang, H., Li, C., Zhang, J. Z. H. & Ji, C. MolGpka: A web server for small molecule pK(a) prediction using a graph-convolutional neural network. J. Chem. Inf. Model 61, 3159\u20133165 (2021).","journal-title":"J. Chem. Inf. Model"},{"key":"70914_CR67","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1021\/ci100031x","volume":"50","author":"PC Hawkins","year":"2010","unstructured":"Hawkins, P. C., Skillman, A. G., Warren, G. L., Ellingson, B. A. & Stahl, M. T. Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database. J. Chem. Inf. Model 50, 572\u2013584 (2010).","journal-title":"J. Chem. Inf. Model"},{"key":"70914_CR68","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/jcc.23702","volume":"35","author":"EL Wu","year":"2014","unstructured":"Wu, E. L. et al. CHARMM-GUI membrane builder toward realistic biological membrane simulations. J. Comput Chem. 35, 1997\u20132004 (2014).","journal-title":"J. Comput Chem."},{"key":"70914_CR69","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","volume":"9","author":"DR Roe","year":"2013","unstructured":"Roe, D. R. & Cheatham, T. E. 3rd. PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data. J. Chem. Theory Comput 9, 3084\u20133095 (2013).","journal-title":"J. Chem. Theory Comput"},{"key":"70914_CR70","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/cyto.a.20647","volume":"75","author":"MB Jimenez-Diaz","year":"2009","unstructured":"Jimenez-Diaz, M. B. et al. Quantitative measurement of Plasmodium-infected erythrocytes in murine models of malaria by flow cytometry using bidimensional assessment of SYTO-16 fluorescence. Cytom. A 75, 225\u2013235 (2009).","journal-title":"Cytom. A"},{"key":"70914_CR71","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01574-22","volume":"67","author":"C Demarta-Gatsi","year":"2023","unstructured":"Demarta-Gatsi, C. et al. Predicting optimal antimalarial drug combinations from a standardized Plasmodium falciparum humanized mouse model. Antimicrob. Agents Chemother. 67, e0157422 (2023).","journal-title":"Antimicrob. Agents Chemother."},{"key":"70914_CR72","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/978-1-4939-9236-2_19","volume":"1978","author":"S Agrawal","year":"2019","unstructured":"Agrawal, S. et al. El-MAVEN: A fast, robust, and user-friendly mass spectrometry data processing engine for metabolomics. Methods Mol. Biol. 1978, 301\u2013321 (2019).","journal-title":"Methods Mol. Biol."},{"key":"70914_CR73","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.bbrc.2013.11.103","volume":"443","author":"H Fang","year":"2014","unstructured":"Fang, H. & Gough, J. supraHex: an R\/Bioconductor package for tabular omics data analysis using a supra-hexagonal map. Biochem Biophys. Res Commun. 443, 285\u2013289 (2014).","journal-title":"Biochem Biophys. Res Commun."},{"key":"70914_CR74","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1021\/acs.jmedchem.3c01795","volume":"67","author":"JA Gilleran","year":"2024","unstructured":"Gilleran, J. A. et al. Structure-activity relationship of a pyrrole based series of PfPKG inhibitors as anti-malarials. J. Med. Chem. 67, 3467\u20133503 (2024).","journal-title":"J. Med. Chem."},{"key":"70914_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42801-x","volume":"9","author":"M Penzo","year":"2019","unstructured":"Penzo, M. et al. High-throughput screening of the Plasmodium falciparum cGMP-dependent protein kinase identified a thiazole scaffold which kills erythrocytic and sexual stage parasites. Sci. Rep. 9, 7005 (2019).","journal-title":"Sci. Rep."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70914-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70914-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70914-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:02:53Z","timestamp":1781827373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70914-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70914"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70914-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5441"}}